1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Attention Is All You Need for De-Escalation: A Time-Series Transformer Meta-Analysis of Dynamic PET Kinetics and Toxicity in Hodgkin Lymphoma

HL - 1613

Attention Is All You Need for De-Escalation: A Time-Series Transformer Meta-Analysis of Dynamic PET Kinetics and Toxicity in Hodgkin Lymphoma

Faiza Khalid

Poster Presenter: Faiza Khalid

MM - 956

Autologous Stem Cell Transplantation for Multiple Myeloma: Real World Outcomes from a Single Centre in Pakistan

Kashaf ad Duja Awais

Poster Presenter: Kashaf ad Duja Awais

$Thumbnail for Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in a Resource-Limited Setting: A Real-World Study From Pakistan$

SOHO 2026 Annual Meeting

Posters by Title

Attention Is All You Need for De-Escalation: A Time-Series Transformer Meta-Analysis of Dynamic PET Kinetics and Toxicity in Hodgkin Lymphoma

Autologous Stem Cell Transplantation for Multiple Myeloma: Real World Outcomes from a Single Centre in Pakistan

Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in a Resource-Limited Setting: A Real-World Study From Pakistan

Autologous Stem Cell Transplantation Remains an Effective Strategy in Mantle Cell Lymphoma in a Brazilian Real-World Cohort

Automated Extraction of Adverse Events Reveals Relationship Between HMA/Ven Cycle Duration and Symptom Burden

Avapritinib Treatment of Patients with Advanced Systemic Mastocytosis: 4-Year Safety, Effect on Bone and First-Line Efficacy Results of the PATHFINDER Clinical Study

Baseline Monocyte-Macrophage Exhaustion and NK-Cell Dysfunction Could Predict Response, Minimal Residual Disease, and Survival and Guide Treatment Choice in Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Baseline Predictors of Survival and Spleen Response in Ruxolitinib-Treated Myelofibrosis: Development of the Ruxolitinib Prognostic Scoring System in a Real-World Cohort

Baseline Protein-Energy Malnutrition Identifies a High-Risk Phenotype in HMA-Treated Myelodysplastic Syndromes: A Propensity-Matched Real-World Analysis